Session 896: Tumor suppressor genes

Date: 2 February 2004, Time: 14:00 - 16:00
Location: Room 2

Oral Presentations

Time	Number	Title / Authors / Affiliations
14:00	69	Evidence for selective expression of the p53 codon 72 polymorphs: implications in cancer development K Sabapathy PhD, MM Siddique MSc, C Balram PhD, P Tan MD PhD National Cancer Centre, Singapore 169610, Singapore and
14:15	70	P53 codon 72 polymorphism and risk of conjunctival squamous cell carcinoma in Uganda ML Tornesello^a, K Waddell^b, ML Duraturo^a, B Biryahwaho^c, R Downing^c, SB Lucas^d, L Buonaguro^a, FM Buonaguro^a (a) Viral Oncology and AIDS Reference Centre, Natl. Cancer Inst. "Fond. Pascale", Naples, Italy; (b) Uganda Eye Project, PO Box 4008 Kampala, Uganda; (c) Uganda Virus Research Institute, PO Box 49 Entebbe, Uganda; (d) Department of Histopathology, UCL Medical School, London, UK
14:30	71	A functional genomic strategy for the fine mapping of a tumor suppressor gene interval: application to chromosome 3p12 K Zhang PhD^a, ST Lott PhD^b, L Jin PhD^c, AM Killary PhD^b ^aDepartment of Genetics, Harvard Medical School, Boston, MA, United States, ^bDepartment of Molecular Genetics, UT-MD Anderson Cancer Center, Houston, TX, United States, ^cCenter for Genome Information, Department of Environmental Health, University of Cincinnati, Cincinnati, OH, United States
14:45	72	BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia G Palomba PhD^a, M Pisano PhD^a, A Cossu MD^b, MF Dedola MD^c, A Farris MD^d, A Contu MD^e, MP Satta, S Tech^a, MC Sini PhD^a, PP Demuro PhD^a, C Rozzo PhD^a, M Casula PhD^a, M Colombino PhD^a, A Manca PhD^a, P Baldinu PhD^a, AA Carboni MD^b, A Deiana MD^b, F Tanda MD^b, G Palmieri MD^a ^aICB-CNR, Alghero, Sassari, ^bInstitute of Pathology, University of Sassari, A.S.L.1, Sassari, ^cDept. of Radiotherapy, ^dMedical Oncology; University of Sassari, A.S.L.1, Sassari, ^eDept. of Medical Oncology, A.S.L.1, Sassari, Italy
15:00	73	Identification of a novel candidate gene, MENC, in a consensus region of allelic deletion at chromosome 10q26 in human endometrial cancer P Baldinu PhD^a, A Cossu MD^b, A Manca PhD^a, MP Satta, S Tech^a, MC Sini PhD^a, C Rozzo PhD^a, M Pisano PhD^a, M Casula PhD^a, M Colombino PhD^a, PP Demuro PhD^a, G Palomba PhD^a, A Pintus MD^b, A Deiana MD^b, S Dessole MD^c, PL Cherchi MD^c, F Tanda MD^b, G Palmieri MD^a (a)ICB-CNR, Alghero; (b)Istituto di Anatomia Patologica, Università di Sassari; (c)Dipartimento di Ostetricia e Ginecologia, Università di Sassari; Italy.

Poster Presentations

Number	Title / Authors / Affiliations
74	Role of p53 in the cellular responsiveness/resistance to glucocorticoid hormone-mediated growth arrest in a rat glioma model. AFA Macedo BS, MAA Demasi BS, LH Carvalho PhD, MC Sogayar PhD Instituto de Química, Universidade de São Paulo, São Paulo, SP, Brasil, mcsoga@iq.usp.br
75	Inhibition of intestinal carcinogenesis by NSAIDs: complementary action of polyamines NA Ignatenko PhD^a, N Babbar PhD^b, K Blohm-Mangone BS^c, J Padilla-Torres BS^c, EW Gerner PhD^a,b ^aDepartment of Cell Biology and Anatomy, ^bBiochemistry & Molecular Biophysics, ^cCancer Biology Division; Arizona Cancer Center, The University of Arizona, Tucson, AZ, United States
76	Analysing p53-gene mutations: Comparison of capillary electrophoresis Single Strand Conformation Polymorphism method with Denaturing Gradient Gel Electrophoresis method and direct sequencing R Holmila MSc, K Husgafvel-Pursiainen PhD Finnish Institute of Occupational Health, Helsinki, Finland
77	Immunohistochemical Analysis of p53 And Bcl2 in Esophageal Cancer Patients. S Arbabi *(a); E Fathi, PharmD (b); B Minaee, PhD (c); E Azizi, PhD(a) ^aMolecular research Lab, Dept. of Pharmacology and Toxicology, Faculty of Pharmacy, ^bSchool of pharmacy; Islamic Azad university of medical sciences and, Tehran, Iran, ^cDept. of Anatomy and Embriology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
78	P53 and Akt expression during osteoblast differentiation. C Feig BS, K Kolman BS, N Chandar PhD Department of Biochemistry, Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL, United States
421	Diagnosis of cervical intraepithelial lesions by integrated cell and tissue changes HE Nieburgs MD Department of Pathology, University of Massachusetts Medical School, Worcester, MA, United States